Bryan F. Cox - 05 Oct 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Reporting relationship: Chief of Research
Issuer ticker: TLSI
Reported as of: 05 Oct 2026
Net transaction value: -$1,299
SEC form: 4
Accepted by SEC: 07 Oct 2026, 16:02:52 UTC
Prior SEC filing: 20 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mary Szela, Attorney-in-Fact

Filing notes and source

Key filing fact

Bryan F. Cox filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 07 Oct 2026.

Key facts

This page summarizes Bryan F. Cox's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Oct 2026, 16:02.

Change

Previous filing in this sequence was filed on 20 Mar 2026.
Current net transaction value: -$1,299.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001981787 Primary reporting owner

Cox Bryan F.

Relationship: Chief of Research
Address: 6272 W. 91ST AVENUE, WESTMINSTER
Signature: /s/ Mary Szela, Attorney-in-Fact
Signature date: 07 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSI transaction

Common Stock

Sale

Transaction value: -$1,299
Shares: -296
Change %: -0.18%
Price: $4.39
Shares after: 162,805
Date: 05 Oct 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Bryan F. Cox is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person.